论文部分内容阅读
在来曲唑 (ｌｅｔｒｏｚｏｌｅ ,Ｆｅｍａｒａ)和阿那曲唑 (ａｎａｓ ｔｒｏｚｏｌｅ ,Ａｒｉｍｉｄｅｘ)的第一轮比较中 ,通过将两者应用于罹患乳腺癌 (局部浸润或已转移 )并且抗雌激素治疗失败的绝经后妇女 ,芳香酶抑制剂来曲唑的完全及部分显效率均高于阿那曲唑 5 0 %。但是
In the first round of comparisons of letrozole (Femara) and anastrozole (Arimidex), both were tested by applying both to menopause with breast cancer (locally infiltrating or metastasized) and failure of anti-estrogen therapy After the women, the aromatase inhibitor letrozole complete and partial markedly higher efficiency than anastrozole 50%. but